Skip to main content
Clinical Trials/NCT02711722
NCT02711722UnknownNot Applicable

Reduced Unloading in NAVA Improves Distribution of Ventilation in ICU Patients

Karolinska University Hospital1 site in 1 country12 target enrollmentStarted: June 1, 2015Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
12
Locations
1
Primary Endpoint
Center of Ventilation (CoV), expressed in percent (ventral to dorsal)

Study Overview

Brief Summary

Title: Reduced Unloading in NAVA Improves distribution of Ventilation in ICU patients.

Objectives:

  1. To investigate if NAVA targeted to moderate respiratory muscular unloading results in redistribution of ventilation to the dorsal regions of the lungs
  2. To verify if the redistribution of ventilation translates to a better gas exchange and to a potentially lung protective ventilation strategy (lower airway pressures)
  3. To verify the possibility to set NAVA at different levels of unloading, based on Neuro-Ventilatory Efficiency.

Study Design: Randomised Crossover of Pressure Support and NAVA at different levels of unloading.

Population: Adult Intubated patients at the Neurosurgical ICU, ventilated for more than 48h, in weaning phase from mechanical ventilation.

Study duration: 2,5h Number of subjects: 12

Detailed Description

Critically ill patients on mechanical ventilation are at risk for developing respiratory muscle atrophy. Partial Assist modes such Pressure Support (PS) and Neurally Adjusted Ventilatory Assist (NAVA) are developed to maintain patients´own effort in breathing. However there are no recommendations on how to set the optimal ventilator support in NAVA to avoid over- or underassistance.

A previous Electrical Impedance Thomography (EIT) study has shown a redistribution of ventilation towards the dorsal regions of the lung in acute lung injury patients ventilated with NAVA, compared to PS.

In the present study, the assist is targeted to different respiratory muscle unloading, predefined and based on the Neuro-Ventilatory Efficiency (NVE). The NVE will be measured at 10min intervals and NAVA level adjusted if needed, to keep constant the level of unloading in each study step.

Protocol: Once enrolled, the patients are ventilated in PS (PScli1) as set by the clinician. They are then ventilated in NAVA at 3 different levels of muscle unloading in randomized order. At NAVAcli, the assist level matches to PScli1 in terms of muscle unloading. With NAVA40% and NAVA60%, the patients have 40% and 60% unloading, respectively. In the last study step the patients are back to PS (PScli2). Each patient is his/her own control and goes through the 5 ventilation periods, of 30min each. In the last 5 min of each study step, the CoV (obtained through the EIT data), blood gas samples (for oxygenation and ventilation) and ventilatory parameters are obtained and analyzed.

The investigators hypothesize that

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients belonging to Neurosurgical ICU
  • •Intubated for ≥48h
  • •Weaning phase from Mechanical Ventilation

Exclusion Criteria

  • •bleeding disorders (PK INR>1,5 or APTT>50s or platelet count <50000/µL) or
  • •unstable intracranial pressure (ICP>20 mmHg during the latest 8 hours) or
  • •unstable circulation (requiring high vasopressor dose, for example Noradrenalin >0,2µg/kg/min) or
  • •too severe lung disease (PFI ≤ 26,7 kPa or PEEP >10 cmH2O or FiO2>0,5 at study entry point) or
  • •fever> 38,5°C or
  • •tendency to hyperventilation (PaCO2 < 4,5 kPa at study entry point).

Arms & Interventions

PScli1

Active Comparator

Patients are ventilated in Pressure support (PS) according to the Clinical settings for 30min.

Intervention: PScli1 (Device)

NAVAcli

Active Comparator

Patients are ventilated in Neurally Adjusted Ventilatory Assist (NAVA) and the assist is set in order to match to respiratory muscle unloading reached with PScli1. Patients are ventilated in NAVAcli for 30min.

Intervention: Neurally adjusted ventilatory assist (Device)

NAVA40%

Active Comparator

Patients are ventilated in Neurally Adjusted Ventilatory Assist (NAVA) and the assist is set in order to target 40% muscle unloading based on the Neuro-Ventilatory Efficiency (NVE) measurement. Patients are ventilated in NAVA40% for 30min.

Intervention: Neurally adjusted ventilatory assist (Device)

NAVA60%

Active Comparator

Patients are ventilated in Neurally Adjusted Ventilatory Assist (NAVA) and the assist is set in order to target 60% muscle unloading based on the Neuro-Ventilatory Efficiency (NVE) measurement. Patients are ventilated in NAVA60% for 30min.

Intervention: Neurally adjusted ventilatory assist (Device)

PScli2

Active Comparator

Patients return to PS ventilation, according to the Clinical settings as in PScli1 for 30min.

Intervention: PScli2 (Device)

Outcomes

Primary Outcomes

Center of Ventilation (CoV), expressed in percent (ventral to dorsal)

Time Frame: Total study time is 2,5 hours

The distribution of ventilation is summarized by the CoV, a parameter obtained by the EIT monitor. Recordings are made at the end of each study step (total 5), lasting 30min.

Secondary Outcomes

  • Gas Exchange (PaO2 and PaCO2)(During the last 5min of each study step (each 30min), total 5 steps. Total study time 2,5 hours)
  • Airway Pressure(2,5 hours)
  • Muscle unloading based on Neuro-Ventilatory Efficiency and Neuro-Mechanica Efficiency(2,5 hours)

Investigators

Sponsor
Karolinska University Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Peter Sackey

Associate professor

Karolinska University Hospital

Study Sites (1)

Loading locations...

Similar Trials